Home / Research Library / Patent granted in India to JENNEWEIN BIOTECHNOLOGIE GMBH
GIPResearch.com · Patent and Technology Research
Patent granted in India to JENNEWEIN BIOTECHNOLOGIE GMBH
As per patent office journal dated 27/08/2021 , patent number 374974 has been granted to JENNEWEIN BIOTECHNOLOGIE GMBH that is titled PROCESS FOR PURIFICATION OF A NEUTRAL HUMAN MILK OLIGOSACCHARIDE USING SIMULATED MOVING BED CHROMATOGRAPHY.
Patent granted in India to JENNEWEIN BIOTECHNOLOGIE GMBH — research background
Research context: This article preserves existing publication material for continuity. Technical, commercial and legal references should be checked against current primary sources before making decisions.
As per patent office journal dated 27/08/2021, patent number 374974 has been granted to JENNEWEIN BIOTECHNOLOGIE GMBH that is titled PROCESS FOR PURIFICATION OF A NEUTRAL HUMAN MILK OLIGOSACCHARIDE USING SIMULATED MOVING BED CHROMATOGRAPHY.
The primary independent claim of this patent states a process for purification of a neutral human milk oligosaccharide in a continuous chromatography from a crude solution comprising the neutral human milk oligosaccharide and contaminants, wherein the crude solution comprising the neutral human milk oligosaccharide and contaminants comprises or consists of a solution which is selected from the group consisting of microbial fermentation extract, biocatalysis reaction solution, chemical synthesis solution, and combinations thereof, wherein the purity of the neutral human milk oligosaccharide in the solution is <80 %, characterized in that the crude solution is applied to at least one purification step using simulated moving bed chromatography, wherein a purified solution comprising the neutral human milk oligosaccharide with a purity of 80 % is provided and wherein the purified solution is spray-dried, and neutral HMO is selected from the group consisting of 2’- fucosyllactose, 3-fucosyllactose, 2’,3-difucosyllactose, lacto-N-triose II, lacto-Ntetraose, lacto-N-neotetraose, lacto-N-fucopentaose I, lacto-N-neofucopentaose I, lacto-N-fucopentaose II, lacto-N-fucopentaose III, lacto-N-fucopentaose V, lactoN-neofucopentaose V, lacto-N-difucohexaose I, lacto-N-difucohexaose II, 6’- galactosyllactose, 3’-galactosyllactose, lacto-N-hexaose, lacto-N-neohexaose, para-lacto-N-hexaose, para-lacto-N-neohexaose and difucosyl-lacto-N-neohexaose, most preferably, the neutral HMO is 2´-fucosyllactose or lacto-N-tetraose.
During the patent prosecution, the patent examiner objected to this patent under section 3(d) of the Indian Patents Act. The patent applicant responded to this objection by stating that amended claims of the present invention are a novel process and not a mere use of known process. Therefore, the present invention does not fall under section 3(d) of the Patents Act.
This patent falls under the category of Chemical. Overall, this patent covers a process for purification of a neutral human milk oligosaccharide in a continuous chromatography from a crude solution comprising the neutral human milk oligosaccharide and contaminants, wherein the crude solution comprising the neutral human milk oligosaccharide and contaminants comprises or consists of a solution which is selected from the group consisting of microbial fermentation extract, biocatalysis reaction solution, chemical synthesis solution, and combinations thereof, wherein the purity of the neutral human milk oligosaccharide in the solution is <80 %, characterized in that the crude solution is applied to at least one purification step using simulated moving bed chromatography, wherein a purified solution comprising the neutral human milk oligosaccharide with a purity of 80 % is provided and wherein the purified solution is spray-dried, and neutral HMO is selected from the group consisting of 2’- fucosyllactose, 3-fucosyllactose, 2’,3-difucosyllactose, lacto-N-triose II, lacto-Ntetraose, lacto-N-neotetraose, lacto-N-fucopentaose I, lacto-N-neofucopentaose I, lacto-N-fucopentaose II, lacto-N-fucopentaose III, lacto-N-fucopentaose V, lactoN-neofucopentaose V, lacto-N-difucohexaose I, lacto-N-difucohexaose II, 6’- galactosyllactose, 3’-galactosyllactose, lacto-N-hexaose, lacto-N-neohexaose, para-lacto-N-hexaose, para-lacto-N-neohexaose and difucosyl-lacto-N-neohexaose, most preferably, the neutral HMO is 2´-fucosyllactose or lacto-N-tetraose.
Our team of advancedpatent attorneysassists clients with patent searches, drafting patent applications, and patent (intellectual property) agreements, including licensing and non-disclosure agreements.Advocate Rahul Dev is aPatent Attorney& International Business Lawyerpracticing Technology, Intellectual Property & Corporate Laws. He is reachable atrd (at) patentbusinesslawyer (dot) com&@rdpatentlawyeron Twitter.Quoted in and contributed to 50+ national & internationalpublications(Bloomberg, FirstPost, SwissInfo, Outlook Money, Yahoo News, Times of India, Economic Times, Business Standard, Quartz, Global Legal Post, International Bar Association, LawAsia, BioSpectrum Asia, Digital News Asia, e27, Leaders Speak, Entrepreneur India, VCCircle, AutoTech).Regularly invited tospeakat international & national platforms (conferences, TV channels, seminars, corporate trainings, government workshops) on technology, patents, business strategy, legal developments,leadership & management.Working closely withpatent attorneysalong withinternational law firmswith significant experience withlawyers in Asia Pacificproviding services to clients in US and Europe. Flagship services includeinternational patent and trademark filings, patent services in Indiaand global patent consulting services.Global Blockchain Lawyers (www.GlobalBlockchainLawyers.com) is a digital platform to discuss legal issues, latest technology and legal developments, and applicable laws in the dynamic field of Digital Currency, Blockchain, Bitcoin, Cryptocurrency and raising capital through the sale of tokens or coins (ICO or Initial Coin Offerings).Blockchain ecosystem in India is evolving at a rapid pace and a proactive legal approach is required by blockchain lawyers in Indiato understand the complex nature of applicable laws and regulations.
Discuss a research question related to Patent granted in India to JENNEWEIN BIOTECHNOLOGIE
Describe your objective and the evidence you need. The suitability and scope of any research engagement will be confirmed individually.
Source and context: Original GIPResearch.com publication dated 2021-08-31. Existing text is retained for historical continuity. Verify time-sensitive matters using official records.